Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Very disappointing correction -- we'll see how they handle the '584

This PR should remind and sober everyone in leadership at PTSC to understand that the MMP, and transparency about the MMP, should be addressed and discussed, and that the MMP and not PDSG, is central to the continued existance and independence of this company.

The reexam cert is due to be published next week (thanks LL), we'll see how they handle the '584 news. My bet is on utter silence.


Share
New Message
Please login to post a reply